Cavan-Monaghan Mental Health Service, Drumalee Primary Care Centre, Cavan, Ireland; School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Schizophr Res. 2022 Oct;248:124-130. doi: 10.1016/j.schres.2022.08.009. Epub 2022 Aug 29.
While associations between duration of untreated psychosis (DUP) and outcome have been widely reported, how long these relationships endure following initiation of treatment and how such associations are distributed across the range of DUP values encountered remain unclear. This study investigates prospectively (i) whether prediction of outcome by DUP and by duration of untreated illness (DUI) diminishes, remains stable or increases in the long term after initiating treatment, and (ii) whether these relationships for differing indices of outcome vary across gradations of DUP-DUI values. Sixty-two subjects were evaluated prospectively for DUP, DUI, premorbid features, psychopathology and quality of life at both first episode psychosis (FEP) and at 7-year follow-up; functionality and service engagement were assessed at follow-up. Data were analysed using mixed-effects models for DUP and DUI quantiles. Prediction by longer DUP and DUI of greater psychopathology, particularly negative symptoms, and lower quality of life remained stable between FEP and follow-up; longer DUP and DUI also predicted lower functionality and service engagement at follow-up. While most associations were confined to the longest DUP-DUI quartile, those between DUP-DUI and negative symptoms and quality of life were distributed in a graded manner across DUP-DUI quartiles. Material confounding with premorbid features, including lead-time bias, was not supported. These findings suggest that benefits of reducing DUP-DUI may endure for at least a decade beyond FEP and that even modest reductions in DUP-DUI may confer particular advantage in the more debilitating and intransigent domain of impairment.
虽然未治疗精神病期(DUP)与结局之间的关联已被广泛报道,但在开始治疗后这些关系能持续多久,以及这些关联在遇到的 DUP 值范围内是如何分布的,仍不清楚。本研究前瞻性地调查了:(i)在开始治疗后,DUP 和未治疗疾病期(DUI)对结局的预测是否会减少、保持稳定或增加;(ii)这些不同结局指标的关系在 DUP-DUI 值的不同梯度上是否有所不同。62 名首发精神病患者在首次发病(FEP)时和 7 年随访时同时评估 DUP、DUI、病前特征、精神病理学和生活质量;在随访时评估功能和服务参与度。使用混合效应模型对 DUP 和 DUI 分位数进行数据分析。更长的 DUP 和 DUI 预测更严重的精神病理学,尤其是阴性症状和较低的生活质量,在 FEP 和随访之间保持稳定;更长的 DUP 和 DUI 还预测随访时较低的功能和服务参与度。虽然大多数关联仅限于最长的 DUP-DUI 四分位数,但 DUP-DUI 与阴性症状和生活质量之间的关联在 DUP-DUI 四分位数中呈梯度分布。与病前特征相关的物质混杂,包括领先时间偏差,没有得到支持。这些发现表明,减少 DUP-DUI 的益处可能在 FEP 之后至少持续十年,即使 DUP-DUI 略有减少,也可能在更具致残性和顽固性的损害领域带来特别的好处。